Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_assertion type Assertion NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_head.
- NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_assertion description "[Our data uncover a FoxO6-dependent pathway by which the liver orchestrates insulin regulation of gluconeogenesis, providing the proof-of-concept that selective FoxO6 inhibition is beneficial for curbing excessive hepatic glucose production and improving glycemic control in diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_provenance.
- NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_assertion evidence source_evidence_literature NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_provenance.
- NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_assertion SIO_000772 21940782 NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_provenance.
- NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_assertion wasDerivedFrom befree-20140225 NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_provenance.
- NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_assertion wasGeneratedBy ECO_0000203 NP823473.RABSqyKARl6AN_nEukEAPXOV8bxyWEg9Fl48zCMUh-Ol8130_provenance.